» Articles » PMID: 37362475

Spinal Myxopapillary Ependymoma: A Rare Case and Review of Management Strategies

Overview
Journal Cureus
Date 2023 Jun 26
PMID 37362475
Authors
Affiliations
Soon will be listed here.
Abstract

Intramedullary myxopapillary ependymomas are rare spinal cord tumors primarily affecting young adults. Grade 2 tumors are associated with a higher proliferative index and potentially more aggressive behavior compared to grade 1 tumors. We present a case of a 30-year-old male who presented with a three-month history of progressive unilateral lower back pain that was refractory to analgesics. Neurological examination revealed bilateral lower limb weakness and sensory impairments in the L2 region. MRI confirmed a well-defined, enhancing intramedullary lesion at the L2 level, causing cord enlargement and edema. Diagnosis of grade 2 intramedullary myxopapillary ependymoma was made. Complete surgical resection was performed, confirming a grade 2 myxopapillary ependymoma. Postoperatively, the patient demonstrated significant improvement in lower limb function and sensation, with no tumor recurrence during long-term follow-up. Rehabilitation therapy was initiated, while close monitoring for complications and tumor progression was maintained. This case explores the etiology and features of intramedullary myxopapillary ependymomas and underscores the importance of early recognition, accurate diagnosis, and aggressive surgical management.

Citing Articles

From Diagnosis to Resolution: A Case Study of Myxopapillary Ependymoma Survival.

Al-Banna M, Abughazal M, Aljanabi M, Hassan M, Abouelkheir M Cureus. 2024; 16(9):e68490.

PMID: 39364501 PMC: 11447257. DOI: 10.7759/cureus.68490.


Unusual location of myxopapillary ependymoma in the sacrum: Case report and review of the literature.

Kouhen F, Mjabbar R, Alami R, El Gouach H, Cherkaoui Jaouad M, Benslima N Radiol Case Rep. 2024; 19(4):1489-1495.

PMID: 38312753 PMC: 10835126. DOI: 10.1016/j.radcr.2023.12.010.

References
1.
Villano J, Parker C, Dolecek T . Descriptive epidemiology of ependymal tumours in the United States. Br J Cancer. 2013; 108(11):2367-71. PMC: 3681017. DOI: 10.1038/bjc.2013.221. View

2.
Pesce A, Palmieri M, Armocida D, Frati A, Miscusi M, Raco A . Spinal Myxopapillary Ependymoma: The Sapienza University Experience and Comprehensive Literature Review Concerning the Clinical Course of 1602 Patients. World Neurosurg. 2019; 129:245-253. DOI: 10.1016/j.wneu.2019.05.206. View

3.
Marchesini N, Tommasi N, Faccioli F, Pinna G, Sala F . Cauda equina ependymomas: surgical treatment and long-term outcomes in a series of 125 patients. J Neurosurg Spine. 2021; 36(3):452-463. DOI: 10.3171/2021.5.SPINE202049. View

4.
Sonneland P, Scheithauer B, Onofrio B . Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer. 1985; 56(4):883-93. DOI: 10.1002/1097-0142(19850815)56:4<883::aid-cncr2820560431>3.0.co;2-6. View

5.
Bagley C, Wilson S, Kothbauer K, Bookland M, Epstein F, Jallo G . Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev. 2009; 32(3):321-34. DOI: 10.1007/s10143-009-0190-8. View